Wuhan Dapeng Pharmaceutical Industry

Wuhan Dapeng Pharmaceutical Industry Co., Ltd. is a specialized pharmaceutical manufacturer based in Wuhan, China, and a core subsidiary of the Grand Pharmaceutical Group. The company focuses on the research, development, and large-scale production of high-end chemical active pharmaceutical ingredients (APIs) and finished drug products. Its therapeutic portfolio primarily targets oncology, cardiovascular health, and anti-infective treatments. Key commercial products include essential anti-cancer medications such as Letrozole, Anastrozole, and Temozolomide. Operating from the Wuhan East Lake High-tech Development Zone, the company maintains state-of-the-art, GMP-compliant manufacturing facilities. Wuhan Dapeng plays a significant role in the global pharmaceutical supply chain, exporting its products to numerous international markets.